ALB and cancer: Among the several scoring systems used to evaluate inflammation‐based nutritional status in patients with cancer, the Glasgow prognostic score (GPS), which is calculated based on C‐reactive protein (CRP) and serum albumin (Alb), is considered a useful tool that reflects systemic immune inflammatory status and predicts prognostic importance.15